During metabolic syndrome (pre-diabetes), in addition to peripheral insulin dysregulation, lipid metabolism might determine the development of peripheral neuropathy, and an impaired brain insulin pathway, increased levels of tau and decreased adiponectin levels might predispose to central neuropathy associated with cognitive deficits. Here, MAPT is linked to Cognitive impairment.